5.2 Valid Prescription Elements & Transmission Standards

5.2 Valid Prescription Elements & Transmission Standards

Quick Answer: Under Tennessee Board of Pharmacy Rule Chapter 1140-03 and T.C.A. § 63-10-204, every valid prescription order must contain complete patient data, prescriber data, full drug details, explicit directions (vague sigs like "use as directed" are unlawful), date of issuance, and a lawful signature. The Tennessee Tamper-Resistant Prescription Paper Act (T.C.A. § 53-10-401) mandates that ALL written outpatient prescriptions (both legend and controlled) must be printed on tamper-resistant paper featuring three distinct security technologies. Under T.C.A. § 63-1-160, all Schedule II–V controlled substances must be prescribed electronically via EPCS, though pharmacists enjoy statutory safe-harbor immunity if they dispense non-electronic prescriptions without verifying exceptions. Facsimile transmissions of Schedule II drugs can serve as the original order in only three narrow clinical settings: home infusion IV compounding, LTCF residents, and hospice patients.

---

1. Statutory Data Elements of a Complete Prescription Order

For a pharmacist to lawfully dispense a medication in Tennessee, the prescription order must be complete and unambiguous on its face. Under T.C.A. § 63-10-204 and Tenn. Comp. R. & Regs. 1140-03-.01, the required elements depend on whether the drug is a non-controlled legend medication or a controlled substance:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     MANDATORY PRESCRIPTION DATA ELEMENTS                    │
├───────────────────────────────────┬─────────────────────────────────────────┤
│ Patient Elements                  │ Prescriber Elements                     │
│ • Full legal name                 │ • Full legal name & practice address    │
│ • Residential home address        │ • Direct telephone number               │
│                                   │ • State professional license number     │
│                                   │ • DEA registration number (if CS)       │
│                                   │ • Supervising MD name (if APRN or PA)   │
├───────────────────────────────────┼─────────────────────────────────────────┤
│ Drug & Dispensing Details         │ Legal Authorization Details             │
│ • Drug name (generic or brand)    │ • Date of issuance (actual date signed) │
│ • Dosage form (e.g., tabs, caps)  │ • Refill authorizations (or "zero")     │
│ • Strength (e.g., 50 mg)          │ • Manual ink signature (written/fax) or │
│ • Quantity prescribed (numeric;   │   cryptographic digital signature (EPCS)│
│   written words also for C-II–V)  │ • ICD-10 code (if acute opioid >3 days) │
│ • Precise directions for use (sig)│                                         │
└───────────────────────────────────┴─────────────────────────────────────────┘

Critical Statutory Nuances

1. Directions for Use (Sig): The directions must be explicit, enabling the patient to understand exactly how, when, and how often to take the medication. Tennessee Board rules strictly prohibit ambiguous sigs such as "Take as directed", "UD", or "PRN" without a designated clinical indication or frequency ceiling.
2. Date of Issuance: The prescription must bear the actual date on which it was created and signed. Post-dating (writing a future date on a prescription) is strictly prohibited under federal law (21 CFR § 1306.05) and Tennessee law. For sequential Schedule II orders, the prescriber must date the prescription with today's date and write "Do not fill before [date]" in the body.
3. Prescriber Identifiers for Mid-Levels: If the prescription is written by an APRN or PA, it must display the name, business address, and telephone number of both the mid-level prescriber AND their delegating/supervising physician.
4. Dual Quantity Notation: On written controlled substance prescriptions, it is best practice and required under anti-fraud regulations that the quantity be expressed both numerically and alphabetically (e.g., "#30 (thirty)") to prevent unauthorized alteration.

---

2. Tennessee Tamper-Resistant Prescription Paper Act (T.C.A. § 53-10-401)

A frequent source of confusion on the MPJE is the difference between federal Medicaid tamper-resistant rules and the Tennessee state statute. While the federal Social Security Act mandates tamper-resistant paper only for outpatient Medicaid (TennCare) prescriptions, the Tennessee Tamper-Resistant Prescription Paper Act (T.C.A. § 53-10-401) universally mandates tamper-resistant paper for ALL written prescriptions issued in Tennessee, regardless of whether the patient pays via commercial insurance, TennCare, Medicare, or cash!

The Three Mandatory Security Characteristics

Under T.C.A. § 53-10-401(a), any written prescription issued by a Tennessee practitioner for any drug or device must be executed on tamper-resistant prescription paper that incorporates at least one feature from each of the following three statutory security categories:

[!IMPORTANT] Scope and Statutory Exemptions: The Tennessee Tamper-Resistant Paper Act applies strictly to written, hard-copy outpatient prescriptions. It does NOT apply to:

• Electronic prescriptions transmitted via EPCS or e-prescribing networks.
• Verbal orders telephoned directly to the pharmacy and reduced to writing by a pharmacist.
• Prescriptions transmitted directly to the pharmacy via facsimile.
• Inpatient medication orders written for administration to patients confined in a hospital, nursing home, or hospice inpatient facility.

---

3. Tennessee Electronic Prescribing Mandate (T.C.A. § 63-1-160)

In 2021, the Tennessee General Assembly enacted a comprehensive electronic prescribing mandate codified at T.C.A. § 63-1-160, requiring healthcare practitioners to issue prescriptions for all Schedule II, III, IV, and V controlled substances electronically.

Electronic Prescribing of Controlled Substances (EPCS) Standards

To be valid, electronic controlled substance prescriptions must be generated and transmitted using an electronic prescribing application and pharmacy receiving software that fully comply with federal DEA EPCS regulations (21 CFR Part 1311):

• Two-Factor Authentication (2FA): Prescribers must authenticate the transmission of a controlled substance order using at least two of the three recognized credential factors: something you know (password/PIN), something you have (hard token, cryptographic key, or smartphone push authenticator), and something you are (biometric fingerprint or iris scan).
• Audit Trails & Digital Signatures: The transmission software must generate a tamper-evident digital cryptographic signature and maintain full audit logs of every transmission.

┌─────────────────────────────────────────────────────────────────────────────┐
│            TENNESSEE CONTROLLED SUBSTANCE E-PRESCRIBING EXCEPTIONS          │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Veterinary Prescriptions (DVMs are exempt from EPCS mandate).            │
│ 2. Technological or Electrical Failure (temporary system outage).           │
│ 3. Out-of-State Dispensing (patient filling prescription outside TN).       │
│ 4. Official Hardship Waivers (granted by licensing board for hardship).     │
│ 5. Research Protocol Prescriptions (approved under FDA/DEA protocols).      │
│ 6. Emergency Circumstances (where delay would cause immediate patient harm).│
│ 7. Standing Orders / Collaborative Pharmacy Practice Protocols (CPPAs).     │
│ 8. Non-Controlled Legend Drugs (mandate strictly applies to Schedules II–V).│
└─────────────────────────────────────────────────────────────────────────────┘

The Pharmacist Safe-Harbor Provision (T.C.A. § 63-1-160(c))

A critical concept tested on the Tennessee MPJE is the statutory protection afforded to dispensing pharmacists:

Pharmacist Non-Verification Immunity: Tennessee law explicitly establishes that a pharmacist who receives a written, oral, or facsimile prescription for a controlled substance is NOT required to verify that an exception to the electronic prescribing mandate applies. A pharmacist may dispense a valid written, verbal, or faxed controlled substance prescription without fear of administrative penalty, disciplinary action, or civil liability. The legal responsibility to transmit controlled substance orders electronically rests squarely upon the prescriber, not the dispensing pharmacist.

---

4. Oral & Facsimile Prescription Transmission Standards

When a prescription is not transmitted electronically, Tennessee law and DEA regulations enforce strict rules governing oral (verbal) and facsimile (fax) communications.

Oral (Telephone) Prescriptions

• Non-Controlled Drugs and Schedules III–V: May be communicated orally by the prescriber or an authorized employee/agent (e.g., nurse, medical assistant) directly to a licensed pharmacist or a pharmacy intern practicing under direct supervision. The pharmacist or intern must promptly reduce the order to writing (either physically or electronically) with all required statutory data elements.
• Schedule II Controlled Substances: Federal (21 CFR § 1306.11) and Tennessee law STRICTLY PROHIBIT oral prescriptions for Schedule II drugs, with one narrow exception: a bona fide emergency situation.

Emergency Oral Schedule II Prescriptions (21 CFR § 1306.11(d))

In an acute emergency where immediate administration of a Schedule II drug is necessary, no alternative non-opioid is available, and it is not reasonably possible for the prescriber to provide a written or electronic prescription, an oral Schedule II order may be dispensed subject to four strict conditions:

1. Quantity Restriction: The quantity prescribed and dispensed must be limited strictly to the amount adequate to treat the patient during the emergency period (not a standard 30-day supply!).
2. Immediate Reduction to Writing: The pharmacist must immediately reduce the oral order to writing, containing all required elements except the prescriber's signature.
3. 7-Day Cover Prescription Mandate: Within seven (7) days of the emergency oral authorization, the prescriber must deliver or have postmarked an original written or valid electronic prescription for the emergency quantity. The face of this covering prescription must be boldly annotated: "Authorization for Emergency Dispensing" and state the date of the oral order.
4. Failure to Deliver Cover: If the prescriber fails to deliver or postmark the covering prescription within 7 days, the pharmacist is statutorily required to notify the DEA Nashville District Office and the Tennessee Board of Pharmacy. Failure of the pharmacist to make this notification invalidates the legal defense for dispensing without a prescription.

Facsimile (Fax) Transmission Regulations

A faxed prescription must be an exact facsimile image of the complete prescription, including the manual signature of the prescriber, transmission date, time, and the sending clinic's facsimile header. Under Tennessee Board Rule Chapter 1140-03, a faxed prescription for a legend drug or Schedule III–V controlled substance serves as the original legal prescription record.

The Three Narrow Schedule II Facsimile Exceptions

Under federal DEA rules (21 CFR § 1306.11) and Tennessee law, a pharmacist cannot dispense a Schedule II prescription from a fax unless the physical, original signed paper prescription is presented before dispensing, EXCEPT in three specific clinical scenarios where the faxed prescription itself serves as the permanent original document:

┌─────────────────────────────────────────────────────────────────────────────┐
│                     THREE LEGAL SCHEDULE II FAX EXCEPTIONS                  │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Home Infusion Compounding:                                               │
│    Schedule II narcotic substance to be compounded for the direct           │
│    parenteral, IV, IM, SQ, or intraspinal infusion to a patient in a        │
│    private residence or hospice setting.                                    │
├─────────────────────────────────────────────────────────────────────────────┤
│ 2. Long-Term Care Facility (LTCF):                                          │
│    ANY Schedule II controlled substance (narcotic or non-narcotic) for a    │
│    resident of a licensed Long-Term Care Facility (nursing home). Must note │
│    "LTCF Patient" on the face.                                              │
├─────────────────────────────────────────────────────────────────────────────┤
│ 3. Hospice Care Program:                                                    │
│    Schedule II narcotic substance for a patient enrolled in a licensed or   │
│    certified hospice care program. The prescriber must explicitly write     │
│    "Hospice Patient" on the prescription face.                              │
└─────────────────────────────────────────────────────────────────────────────┘

---